Trade Summary

2 days ago, Rothblatt Martine A, serving as CHAIRPERSON, CEO at United Therapeutics Corp (UTHR), sold 19,000 shares at $317.97 per share, for a total transaction value of $6,041,414.00. Following this transaction, Rothblatt Martine A now holds 639,489 shares of UTHR.

This sale represents a 3.00% decrease in Rothblatt Martine A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.